Strange trading before the TH.. but could be a good little shake down if the news is grand. I’m picking timelines may be extended due to scattered start times with patients… as picked up from Dicky moo dosing - I think there were a few late starers to the trials or might have been a struggle for patient numbers etc. In which case the push up in SP could be viewed as premature but I really can’t see us being fairly valued at this level regardless if we only had 1 or 2 Antisense drugs to our name.
Otherwise, there is the possibility of adverse events in which case must be reported... similar to mipomersen a patient could have had problems before the trial and has escalated since starting the trial…. just speculation of course.
Perhaps Pfizer is launching a T/O now??
Hopefully we just capitulated ST traders and we have great news about to be released. Still TH is a bit strange!
Just thoughts. Good luck.
Strange trading before the TH.. but could be a good little shake...
-
- There are more pages in this discussion • 119 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
